Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacity of the combination of
cisplatin-5-FU and docetaxel in adapted doses in term of response to treatment without
toxicity
.